Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

FORTRINNSRETTSEMISJON

Med grunnlag i styrefullmakter tildelt av den ordinære generalforsamlingen i NattoPharma ASA ("NattoPharma" eller "Selskapet") den 25. juni 2015 og 20. mai 2016, har styret i Selskapet i styremøte 24. juni 2016, vedtatt å utstede 305 000 nye aksjer, hver med en nominell verdi på NOK 3 pr aksje.Fortrinnsrettsemisjonen vil bli gjennomført ved utstedelse av aksjer til ledende ansatte i forbindelse med selskapets incentiv program i henhold til følgende fordeling; Navn  Stilling  Tildelte Aksjer  Aksjer før Aksjer etter

SHARE ISSUE

Based on the power of attorney granted at the annual general meetings of NattoPharma ASA ("NattoPharma" or "Company") on June 25, 2015 and May 20, 2016, the Board of Directors of NattoPharma has in board proceedings June 24th, 2016 approved a share issue of 305 000 new shares, each with a face value of NOK 3 per share.The share issue will be completed through issuance of new shares to leading employees in accordance with the company’s incentive program according to the following plan; Name  Position / Granted shares  Shares prior Shares after Function

Advenica signs framework agreement with Austrian Defense Forces

Advenica, a leading Swedish cybersecurity company, has recently signed a 10 year framework agreement contract with the Austrian Defense Forces to deliver its broad range of cutting edge cybersecurity solutions, including SecuriVPN and SecuriCDS.For more than 20 years Advenica has delivered solutions to government and defense organisations. This new agreement enables Advenica to deliver its unique encryption technology alongside with Cross Domain Solutions for the coming 10 years, the validity of the framework agreement. The solutions are suitable for permanent installations as well as for

INDUCT AS – NEW BOARD OF DIRECTORS

OSLO, NORWAY – June 27, 2016 – Induct AS is pleased to announce that a new Board of Directors was appointed by the General Shareholder Meeting held on June 24 2016. The new Board members are: Mr. Even Nordstrøm (Chairman) has a long industrial experience at executive levels, including 20 years in the media business during which he also served as CEO in A-pressen and Chairman of the Board in TV2. Prior to that he was consultant in Nexia Management Consulting for 10 years. He is currently Associated partner in First House Media. Mr. Nordstrøm has served in Induct’s Advisory Board for two

INDUCT AS – NEW CONTRACTS AND PARTNERSHIPS TO GROW INDUCT NETWORK IN SPAIN

OSLO, NORWAY – June 27, 2016 – Induct AS has signed several agreements which will further strengthen the Induct Network in Spain. HEALTHCARE: Induct already has a leading position in connecting hospitals and healthcare authorities in Spain. Now, two additional global pharma companies and a healthcare consultancy partner have signed with Induct. Almirall is a global pharmaceutical company dedicated to providing valuable medicines through its R&D, agreements and alliances. Almirall has 2,100 employees, sales presence in 21 countries and €1,400 million in revenues. Esteve is an

CybAero and Jolly agree to three system August delivery

In January of 2014 CybAero signed a major order on three systems with the Chinese company Jolly. Earlier this year CybAero, together with Jolly and their customer CSSC, performed deck-landing tests along the coast of Sweden. The positive results from these tests led to a plan for continued testing. Consequently, CybAero has performed a series of joint tests with the Swedish Navy. The reports, videos and statements from that trial became a cornerstone of the negotiations and discussions between CybAero and Jolly and are a key reason for Jolly speeding up the delivery of the entire

Basware positioned as a Leader in Gartner's 2016 Magic Quadrant for Procure-to-Pay Suites report for second consecutive year

Basware , the global leader in providing networked purchase-to-pay solutions, e-invoicing and innovative financing services, today announced it has been positioned by Gartner, Inc. in the Leaders quadrant of its latest Magic Quadrant for Procure-to-Pay Suites* report. This was the second consecutive year for Basware to be recognized as a Leader in this report, now published for the second time."Basware, which has advocated open business networks, has the world's largest open e-invoicing network and has excelled in end-to-end purchase-to-pay (P2P) solutions and

Verian recognized as a Visionary in Gartner's Magic Quadrant for Procure-to-Pay Suites for the second year running

Verian, a Basware company and leader in cloud-based purchase-to-pay (P2P) solutions, has been placed highest for ability to execute in the Visionaries quadrant of the Magic Quadrant for Procure-to-Pay Suites by Gartner, Inc.* for the second year in a row.With deep P2P functionality, Verian's complementary, native solutions in asset and inventory management and travel and expense reporting enable companies to create seamless workflows and achieve greater spend control. Its collaborative approach to P2P - known as WeProcurement(TM)  - empowers customers to

Readly wins Porter Magazine as its fashion portfolio grows

Readly, the digital magazine newsstand, has added the award-winning global fashion magazine, PORTER, to its portfolio, with immediate effect. Launched in Spring 2014 and powered by NET-A-PORTER.com , PORTER has become the world's most talked-about fashion magazine, raising the bar in what a magazine can do through beautiful curation, a global point of view, authoritative fashion, innovative shopping technology, an international multilingual concierge service and unrivalled international distribution in 60 countries. Published bi-monthly, the magazine is

Vitrolife introduces EmbryoScope+ and broadens time-lapse portfolio

Vitrolife is the market leader of time-lapse systems for use in assisted reproduction. With the introduction of EmbryoScope+, the company can offer an additional high quality time-lapse system for undisturbed culture and improved selection of embryos. EmbryoScope+ has a large capacity in combination with a small footprint, providing an efficient workflow and optimised usage of clinic resources. The product will be introduced at the upcoming ESHRE conference next week in Helsinki, Finland.EmbryoScope+ is a time-lapse system with an integrated incubator. EmbryoScope+ builds on the same

Skanska invests EUR 30M, about SEK 280M, in phase I of an office project in Warsaw, Poland

Skanska has invested EUR 30M, about SEK 280M, in the first phase of the office complex Spark located in Warsaw, Poland. Spark 1 will be nine storeys high with a total leasable area of around 12,300 square meters.The project will offer a number of locations where both people working in the complex and local residents can gather, such as co-work space outside the building and a roof terrace accessible for all tenants. On the roof, Spark will have beehives. Additionally, the architecture will be carefully designed to meet the needs of disabled people and will be the first office building in

Ahlsell acquires Prevex

Ahlsell has acquired all shares of the company Prevex AB. The company's turnover 2015 amounts to approximately SEK 350 million.Prevex is a specialized hardware store chain for professionals, with a strong market position in Gothenburg and Malmö where they operate from three well-located stores. The company has 102 employees and sells mainly to local construction and rental companies. "Gothenburg and Malmö with surroundings are important growth markets for Ahlsell and the acquisition strengthens our position in these regions. Prevex has been successful in recent years, and together we

Final result of SSAB’s rights issue

The final result of SSAB AB’s (publ) (“SSAB”) rights issue shows that 472,856,489 class B shares, corresponding to approximately 98.4 per cent of the shares offered, were subscribed for by the exercise of subscription rights. The remaining 7,733,327 class B shares offered have been allotted to persons who have subscribed for shares without subscription rights. SSAB will receive approximately SEK 5 billion through the rights issue before transaction costs.Allotment of shares that were subscribed for without subscription rights has been made in accordance with the principles outlined in the

Aker ASA: Mandatory notification of trade

Aker ASA (“Aker”) has carried out its first employee share purchase programme for the year.Participants in the share purchase programme were offered a discount of 20 per cent on the closing share price on 24 June 2016. Hence, each participant paid NOK 164.80 per share. All shares will be locked up for a period of three years from delivery of the shares, during which employees will not be able to sell the shares. The following primary insiders have purchased shares: · Øyvind Eriksen, president and CEO, has through the company Erøy AS acquired 74 161 shares in Aker. Mr. Eriksen’s

Making sense of Brexit: What happens next after the vote to leave the EU?

JLL UK CEO  & head of Residential research comments on implications of Brexit on UK property marketThe vote for Brexit brings a new dawn for Britain, with considerable uncertainty and no real precedent. JLL UK CEO Chris Ireland commented: “Even if it is effectively ‘business as usual’ for the UK in terms of trade and legislation until 2018, such a major change will inevitably create uncertainty in the economy and real estate markets. In the event of a well-managed exit these impacts will be largely confined to the UK. “In the short term we may see a weakening in occupier demand. The

Industrifonden exits Accedo with 7x return on investment

The Sweden-based venture capital investor Industrifonden sells its entire holding in Accedo, the global leader in television and video experience services, to SEB Private Equity. In recent years, Accedo has been named one of Sweden's fastest growing companies. The company has SEK 320 million ($40 million) in revenue, more than 100 million users and 400 employees globally. The transaction generates a return of seven times the investment for Industrifonden.Accedo’s TV and video solutions are used by hundreds of millions of people globally. The company has close partnerships with some of the

Invitation to presentation of KappAhl Q3 2015/2016 report

KappAhl will announce its third quarter results (March-May 2016) on Thursday 30 June at 07.30 (CET).A teleconference will be held on the same day, for analysts, media and investors, at 09.00 (CET). The report will be presented by Danny Feltmann, President and CEO and Anders Düring, CFO. The presentation will be held in English and will also be live webcasted at www.kappahl.com, under “Investor Relations”, choose “Reports & presentations ”. Questions can be asked via the teleconference or via the

Altor divests Ferrosan Medical Devices to consortium of Nordic investors

Altor Fund III has signed an agreement to divest Ferrosan Medical Devices (“FMD”), a world-leading provider of gelatine-based topical haemostatic products, to a consortium of private investors. FMD was part of the Ferrosan Group that was acquired in 2005; in 2011 the consumer health business of Ferrosan was sold to Pfizer, while Altor Fund III became the majority owner of FMD. The company employs approximately 200 people at its headquarters in Søborg outside Copenhagen, Denmark and its facility in Szczecin, Poland.”Altor have supported FMD’s large investments in product development which

Wallenstam green bonds listed at Nasdaq Stockholm

As previously announced, the Board of Wallenstam AB (publ) (”Wallenstam”) has taken the decision to list bonds at the Nasdaq Stockholm. Nasdaq Stockholm has approved Wallenstam’s application for admission to trading and the first day of trading for the bonds is today, 27 June 2016.On 20 May 2016, Wallenstam announced the issue of an unsecured bond that will run for two years and mature in May 2018 aimed at refinancing wind turbines in the subsidiary Svensk NaturEnergi, which produces electricity through wind power. The bond loan amounts to SEK 400 million and will run subject to an

Guillaume van Gaver appointed EVP International and new member of Tele2 AB’s Leadership Team

Stockholm - Tele2 AB, (Tele2), (NASDAQ OMX Stockholm: TEL2 A and TEL2 B) today announces that Guillaume van Gaver is appointed Executive Vice President International and member of Tele2 AB’s Leadership Team. Also, Lars Torstensson, Executive Vice President New Growth & Strategy, has decided to leave Tele2 to pursue new opportunities outside of the company.This re-introduction of a Market Area Director role for the markets outside of Sweden and Netherlands ensures renewed focus within the Leadership Team. In his position, Guillaume will oversee Tele2 operations in the Baltics, Kazakhstan,

Proact updates datacentre for leading Baltic bank

A leading bank in the Baltics has chosen Proact as their partner to update their mission critical datacentre environment with a new unified storage solution based on Hitachi Data Systems products and Proact services."The bank needed a state-of-the-art central storage platform with high performance and improved functionality, a solution which matches the new requirements of virtualised infrastructure, provides advanced data services and supports long term growth.  Our Proof of Concept was clearly a success and the customer was very impressed with our technical expertise and ability to

Sobi’s Elocta® (rFVIIIFc) approved in Switzerland for the treatment of haemophilia A

Swedish Orphan Biovitrum AB (publ)  (Sobi™) (STO: SOBI) today announced that the Swiss Agency for Therapeutic Products, Swissmedic, has approved Elocta® (rFVIIIFc) for the treatment of haemophilia A. Elocta is the only recombinant factor VIII Fc fusion protein with an extended half-life approved for haemophilia A treatment in Switzerland to offer prolonged protection against bleeding episodes with prophylactic injections every three to five days. “The Swiss approval of Elocta is an important milestone for the country’s haemophilia A community, offering the potential

There are no items matching the current filter
There are no more items matching the current filter
Back to top